Business · 18/07/1995Updated: 10/18/2026 · 1 min read
FDA to Hold Public Hearing on Regulation of Living Autologous Cell Products for Implantation
Summary
The FDA is hosting a public hearing to gather input on the regulation of products containing living autologous cells, which are manipulated outside the body and used for structural repair or reconstruction, including cosmetic applications.